Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients Post & News admin October 12, 2022 Original Newswise post Newswise — Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors are potentially related to adverse events in patients with metastatic Non-Small-Cell-Lung Cancer (mNSCLC). The article, “PD-1/PD-L1 immuno-checkpoint blockade induces immune-effector cells modulation in metastatic Non-Small-Cell-Lung Cancer (mNSCLC) … Continue reading Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Sbarro Health Research Organization
Category: Post & News
Among the causes of type 1 diabetes is a newly discovered bacterium
Among the causes of type 1 diabetes is a newly discovered bacterium Post & News admin September 26, 2022 Analyzing the inflammatory profile of 54 patients who underwent biopsy, it was shown that those with type 1 diabetes show, at the intestinal mucosa level, a specific inflammatory state, “different” from that present in patients with… Continue reading Among the causes of type 1 diabetes is a newly discovered bacterium
Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors
Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors Post & News admin September 15, 2022 Original Newswise post Newswise — A team of investigators from the Sbarro Institute for Cancer Research and Molecular Medicine, and the Center for Biotechnology(SHRO) at Temple University, including Dr. Antonio Giordano and Dr. Andrea Morrione, in collaboration… Continue reading Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors
Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease
Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease Post & News admin August 31, 2022 Newswise — Studies suggest that Insulin-Like Growth Factor (IGF) plays a central role in pathological growth of proliferative conditions like cancer, and may function as a resistance mechanism adopted by the majority of solid cancers… Continue reading Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease
Immunotherapy Covered in Special Edition of Current Clinical Pathology
Immunotherapy Covered in Special Edition of Current Clinical Pathology Post & News admin August 18, 2022 Newswise — In the latest Current Clinical Pathology publication on Immunotherapy, Sbarro Health Research Organization (SHRO) President, Antonio Giordano, M.D., Ph.D., co-edits the volume, focused on cardiovascular toxicities. The development of immunotherapy in the oncology field has revolutionized the prognosis of… Continue reading Immunotherapy Covered in Special Edition of Current Clinical Pathology
